Preclinical efficacy investigation of human neutrophil elastase inhibitor sivelestat in animal model of psoriasis
Abstract Background Psoriasis is a chronic immune‐mediated inflammatory skin disease manifested by an increased rate of keratinocyte division. Currently, it has been established that the cytokines of the IL‐36 family play a significant role in the initiation and regulation of the inflammatory proces...
Saved in:
Main Authors: | A. S. Zhukov (Author), V. R. Khairutdinov (Author), A. V. Samtsov (Author), M. Krasavin (Author), A. V. Garabadzhiu (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical utility of the neutrophil elastase inhibitor sivelestat for the treatment of acute respiratory distress syndrome
by: Aikawa N, et al.
Published: (2014) -
Usefulness of a selective neutrophil elastase inhibitor, sivelestat, in acute lung injury patients with sepsis
by: Miyoshi S, et al.
Published: (2013) -
Precision therapy for psoriasis patients
by: A. S. Zhukov, et al.
Published: (2020) -
Novel and Modified Neutrophil Elastase Inhibitor Loaded in Topical Formulations for Psoriasis Management
by: Andreia Nunes, et al.
Published: (2020) -
Flavonoids as inhibitors of human neutrophil elastase
by: Katarzyna Jakimiuk, et al.
Published: (2021)